These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33628655)

  • 41. Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe.
    Valverde I; Singh Y; Sanchez-de-Toledo J; Theocharis P; Chikermane A; Di Filippo S; Kuciñska B; Mannarino S; Tamariz-Martel A; Gutierrez-Larraya F; Soda G; Vandekerckhove K; Gonzalez-Barlatay F; McMahon CJ; Marcora S; Napoleone CP; Duong P; Tuo G; Deri A; Nepali G; Ilina M; Ciliberti P; Miller O;
    Circulation; 2021 Jan; 143(1):21-32. PubMed ID: 33166189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular Considerations in Coronavirus Disease 2019 with a Special Focus on Arrhythmia.
    Hu TY; Lee JZ; Asirvatham SJ
    J Innov Card Rhythm Manag; 2020 Aug; 11(8):4191-4198. PubMed ID: 32874745
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients.
    Quagliariello V; Bonelli A; Caronna A; Conforti G; Iovine M; Carbone A; Berretta M; Botti G; Maurea N
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33182653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute Fulminant Myocarditis in a Pediatric Patient With COVID-19 Infection.
    Lara D; Young T; Del Toro K; Chan V; Ianiro C; Hunt K; Kleinmahon J
    Pediatrics; 2020 Aug; 146(2):. PubMed ID: 32747591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint.
    Cappuccio FP; Siani A
    Nutr Metab Cardiovasc Dis; 2020 Jul; 30(8):1227-1235. PubMed ID: 32595085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review.
    Napoli C; Tritto I; Benincasa G; Mansueto G; Ambrosio G
    Ann Med Surg (Lond); 2020 Sep; 57():236-243. PubMed ID: 32802325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute pericarditis in a patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a case report and review of the literature on SARS-CoV-2 cardiological manifestations.
    Patel VD; Patel KH; Lakhani DA; Desai R; Mehta D; Mody P; Pruthi S
    AME Case Rep; 2021; 5():6. PubMed ID: 33634246
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated cardiac troponin I as a predictor of outcomes in COVID-19 hospitalizations: a meta-analysis.
    Malik P; Patel U; Patel NH; Somi S; Singh J
    Infez Med; 2020 Dec; 28(4):500-506. PubMed ID: 33257623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis.
    Tabata S; Imai K; Kawano S; Ikeda M; Kodama T; Miyoshi K; Obinata H; Mimura S; Kodera T; Kitagaki M; Sato M; Suzuki S; Ito T; Uwabe Y; Tamura K
    Lancet Infect Dis; 2020 Sep; 20(9):1043-1050. PubMed ID: 32539988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of morbidity and mortality in COVID-19.
    Gacche RN; Gacche RA; Chen J; Li H; Li G
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1684-1707. PubMed ID: 33629339
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Artificial Intelligence-Based Prediction of Covid-19 Severity on the Results of Protein Profiling.
    Yaşar Ş; Çolak C; Yoloğlu S
    Comput Methods Programs Biomed; 2021 Apr; 202():105996. PubMed ID: 33631640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
    ; Gordon AC; Mouncey PR; Al-Beidh F; Rowan KM; Nichol AD; Arabi YM; Annane D; Beane A; van Bentum-Puijk W; Berry LR; Bhimani Z; Bonten MJM; Bradbury CA; Brunkhorst FM; Buzgau A; Cheng AC; Detry MA; Duffy EJ; Estcourt LJ; Fitzgerald M; Goossens H; Haniffa R; Higgins AM; Hills TE; Horvat CM; Lamontagne F; Lawler PR; Leavis HL; Linstrum KM; Litton E; Lorenzi E; Marshall JC; Mayr FB; McAuley DF; McGlothlin A; McGuinness SP; McVerry BJ; Montgomery SK; Morpeth SC; Murthy S; Orr K; Parke RL; Parker JC; Patanwala AE; Pettilä V; Rademaker E; Santos MS; Saunders CT; Seymour CW; Shankar-Hari M; Sligl WI; Turgeon AF; Turner AM; van de Veerdonk FL; Zarychanski R; Green C; Lewis RJ; Angus DC; McArthur CJ; Berry S; Webb SA; Derde LPG
    N Engl J Med; 2021 Apr; 384(16):1491-1502. PubMed ID: 33631065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial.
    Cadegiani FA; McCoy J; Gustavo Wambier C; Vaño-Galván S; Shapiro J; Tosti A; Zimerman RA; Goren A
    Cureus; 2021 Feb; 13(2):e13492. PubMed ID: 33633920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance of prediction models for short-term outcome in COVID-19 patients in the emergency department: a retrospective study.
    van Dam PMEL; Zelis N; van Kuijk SMJ; Linkens AEMJH; Brüggemann RAG; Spaetgens B; van der Horst ICC; Stassen PM
    Ann Med; 2021 Dec; 53(1):402-409. PubMed ID: 33629918
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra.
    Mortaz E; Bassir A; Dalil Roofchayee N; Dezfuli NK; Jamaati H; Tabarsi P; Moniri A; Rezaei M; Mehrian P; Varahram M; Marjani M; Mumby S; Adcock IM
    Int Immunopharmacol; 2021 Apr; 93():107407. PubMed ID: 33631512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COVID-19 sequelae in adults aged less than 50 years: A systematic review.
    Willi S; Lüthold R; Hunt A; Hänggi NV; Sejdiu D; Scaff C; Bender N; Staub K; Schlagenhauf P
    Travel Med Infect Dis; 2021; 40():101995. PubMed ID: 33631340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of body composition on COVID-19 susceptibility and severity: A two-sample multivariable Mendelian randomization study.
    Freuer D; Linseisen J; Meisinger C
    Metabolism; 2021 May; 118():154732. PubMed ID: 33631142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.
    Rosas IO; Bräu N; Waters M; Go RC; Hunter BD; Bhagani S; Skiest D; Aziz MS; Cooper N; Douglas IS; Savic S; Youngstein T; Del Sorbo L; Cubillo Gracian A; De La Zerda DJ; Ustianowski A; Bao M; Dimonaco S; Graham E; Matharu B; Spotswood H; Tsai L; Malhotra A
    N Engl J Med; 2021 Apr; 384(16):1503-1516. PubMed ID: 33631066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of Serum Angiotensin II Levels in Prognosis of Patients With Coronavirus Disease 2019.
    Ozkan S; Cakmak F; Konukoglu D; Biberoglu S; Ipekci A; Akdeniz YS; Bolayirli IM; Balkan II; Dumanli GY; Ikizceli I
    Crit Care Med; 2021 Jun; 49(6):e613-e623. PubMed ID: 33630767
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early Improvement of Acute Respiratory Distress Syndrome in Patients With COVID-19 in the Intensive Care Unit: Retrospective Analysis.
    Zhan Z; Yang X; Du H; Zhang C; Song Y; Ran X; Zhang A; Yang M
    JMIR Public Health Surveill; 2021 Mar; 7(3):e24843. PubMed ID: 33630743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.